Search Results
Sep 09, 2026, 07:00 ET Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
(none at 60 mg QD)79% ORR and 64% best overall response CR rate with 60 mg QD in combined single and multiple marker lesion patients (n=14), with 100% ORR and 75% best overall response CR rate with 60 mg QD in single marker lesion patients (n=8), supporting planned adjuvant
More news about: Tyra Biosciences
Sep 08, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89
More news about: Paramount Skydance Corporation
Sep 08, 2026, 07:30 ET Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study
and 42.8% for pembrolizumab aloneResults are most pronounced in HPV+ patients, with cORR (80.0% vs 33.3%), CR rate (30.0% vs 0%), and PFS6 improvement (90.0% vs 33.0%) vs pembrolizumab aloneInhibrx will expand the Phase 2 study by approximately
More news about: Inhibrx Biosciences, Inc.
Sep 08, 2026, 06:01 ET PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
with a more favorable safety profile compared with approved CAR T-cell therapies. Seven of nine treated patients (80%) achieved a complete response (CR), including four of six patients who had progressed after conventional CD19-directed CAR T-cell therapy ("CAR after CAR"). All complete responses remained
More news about: PeproMene Bio, Inc.; Institute for Follicular Lymphoma Innovation (IFLI)
Sep 08, 2026, 06:01 ET PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
with a more favorable safety profile compared with approved CAR T-cell therapies. Seven of nine treated patients (80%) achieved a complete response (CR), including four of six patients who had progressed after conventional CD19-directed CAR T-cell therapy ("CAR after CAR"). All complete responses remained
More news about: PeproMene Bio, Inc.; Institute for Follicular Lymphoma Innovation (IFLI)
Sep 08, 2026, 06:01 ET PeproMene Bio gibt die Veröffentlichung bahnbrechender Ergebnisse einer klinischen Phase-1-Studie in The Lancet bekannt, die tiefe und anhaltende vollständige Remissionen bei rezidivierten/refraktären B-Zell-Lymphomen belegen, auch nach vorherigem Versagen einer CD19-CAR-T-Zell-Therapie
günstigeren Sicherheitsprofil im Vergleich zu zugelassenen CAR-T-Zell-Therapien. Sieben von neun behandelten Patienten (80 %) erreichten ein vollständiges Ansprechen (CR), darunter vier von sechs Patienten, bei denen nach einer konventionellen CD19-gerichteten CAR-T-Zell-Therapie eine Progression eingetreten war („CAR
More news about: PeproMene Bio, Inc.; Institute for Follicular Lymphoma Innovation (IFLI)
Sep 03, 2026, 10:30 ET SwitchBot stellt Lock Ultra Max Vision Pro Combo auf der IFA 2026 vor - für schnelleren, smarteren und vielseitigeren Zutritt
zugänglich bleibt. Der wiederaufladbare 4.200-mAh-Hauptakku ermöglicht bei typischer Nutzung eine Laufzeit von bis zu neun Monaten. Eine unabhängige CR123A-Backup-Batterie hält das Schloss betriebsbereit, wenn der Hauptakku zum Laden entnommen oder entladen ist, und unterstützt etwa 500 Ver- oder Entriegelungsvorgänge.Auch
More news about: SwitchBot
Sep 03, 2026, 10:30 ET SwitchBot Launches Lock Ultra Max Vision Pro Combo, Bringing Faster, Smarter, Multi-Way Entry at IFA 2026
accessible in unexpected low-battery situations. Its 4200 mAh rechargeable main battery provides up to 9 months of typical use, while an independent CR123A backup battery keeps the lock operational when the main battery is removed for charging or depleted, supporting approximately 500 locking or unlocking
More news about: SwitchBot
Sep 03, 2026, 10:30 ET SwitchBot Launches Lock Ultra Max Vision Pro Combo, Bringing Faster, Smarter, Multi-Way Entry at IFA 2026
accessible in unexpected low-battery situations. Its 4200 mAh rechargeable main battery provides up to 9 months of typical use, while an independent CR123A backup battery keeps the lock operational when the main battery is removed for charging or depleted, supporting approximately 500 locking or unlocking
More news about: SwitchBot
Sep 03, 2026, 09:00 ET Crunch Franchise Brings Premier Fitness Destinations to Greater Dallas-Fort Worth Area
saunaSouthwest Fitness Holdings, LLC, a subsidiary of CR Fitness Holdings, is projected to be operating nearly 20 Crunch clubs in the state of Texas, along with five in Arizona, by the time Crunch Benbrook and Crunch Burleson open. Its parent company, CR Fitness Holdings, is a leading Crunch Fitness franchisee
More news about: Crunch Fitness
Sep 02, 2026, 09:00 ET Crunch Franchise Expands in Maryville, Tennessee with New Crunch 3.0 Gym
LLC, a subsidiary of CR Fitness Holdings, currently operates 21 Crunch gyms across Georgia, North Carolina, and Tennessee, and is projected to operate nearly 25 locations across those three states, including three in Tennessee, by the time Crunch Maryville opens. Its parent company, CR Fitness Holdings,
More news about: Crunch Fitness
Sep 01, 2026, 11:12 ET 3W Auto-life Celebrates 11th Anniversary With Free Upgrades for 11 Winners and 650 Global Prizes
month, and the 11 winners will be announced after September 22.Eligible US models include the Ford F-150, Ford Bronco, Toyota Tacoma, Honda CR-V, Hyundai Palisade, BMW X3, Tesla Model 3 and Tesla Model Y.Engaging UK and EU Customers via Social PlatformsIn the UK and EU, 3
More news about: 3W Auto-life
Sep 01, 2026, 09:22 ET Happiest Minds Technologies announces merger with ITC Infotech to create a scaled, AI First Global Technology Services Enterprise with US$ 1 billion Revenue by FY28
aggregate minority stake of ~22.1% in Happiest Minds from the Promoter and Promoter entities across two tranches for a total consideration of ₹1,330 Cr (average price of ~₹395/share). Further, the proposed merger will be effected through a share swap, pursuant to which equity shareholders of Happiest
More news about: Happiest Minds Technologies Limited
Sep 01, 2026, 09:00 ET Crunch Franchise Brings Next-Generation Fitness Experience to Rockledge, Florida
for its members.About CR Fitness Holdings, LLC:CR Fitness Holdings LLC, a subsidiary of CR Fitness Holdings, currently operates 63 Crunch gyms in the state of Florida and is on track to operate nearly 65 total by the end of 2026. Its parent company, CR Fitness Holdings, is a leading
More news about: Crunch Fitness
Aug 31, 2026, 09:03 ET Crunch Fitness Franchise Honors 9/11 First Responders with Stair Climb Challenge Remembrance
those who continue to exemplify courage and dedication as first responders.About CR Fitness HoldingsCR Fitness Holdings is a leading franchise group of Crunch Fitness. Comprised of subsidiaries CR Fitness Holdings LLC, Southwest Fitness Holdings LLC, and Blue Ridge Fitness Holdings LLC,
More news about: CR Fitness Holdings, LLC.
Aug 31, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89$914,183,000
More news about: Paramount Skydance Corporation
Aug 31, 2026, 01:25 ET AXISCADES Technologies to Acquire Cloud Wave Technologies, Accelerating Entry into Aerospace Manufacturing
Semiconductor sectors across both domestic and export markets. The company has been consistently growing over the years and is expected to generate 180cr revenue at 22% EBITDA in FY27.The acquisition is a key inorganic step under AXISCADES' Power 930 growth plan, which targets continued expansion
More news about: AXISCADES Technologies Limited
Aug 27, 2026, 07:32 ET African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
CEPI backs Minapharm's Bundibugyo ebolavirus vaccine candidate, based on ProBioGen's proprietary MVA-CR19 platformOSLO, Norway, CAIRO and BERLIN, Aug. 27, 2026 /PRNewswire/ -- Leading African biopharmaceutical
More news about: Minapharm Pharmaceuticals
Aug 27, 2026, 07:27 ET African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
CEPI backs Minapharm's Bundibugyo ebolavirus vaccine candidate, based on ProBioGen's proprietary MVA-CR19 platformOSLO, Norway, CAIRO and BERLIN, Aug. 27, 2026 /PRNewswire/ -- Leading African biopharmaceutical
More news about: Minapharm Pharmaceuticals
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
demonstrating encouraging high-grade event-free survival (HG-EFS), high complete response (CR) rates, and favorable tolerability in high-risk NMIBC patients. The data, which demonstrate encouraging HG-EFS, high CR rates, and a well-tolerated safety profile, were presented at the Society of Urologic Oncology
More news about: DelveInsight Business Research, LLP
Aug 25, 2026, 06:40 ET Seed Coating Market worth $3.80 billion by 2031- Exclusive Report by MarketsandMarkets™
(US), Covestro AG (Germany), BrettYoung (Canada), Chromatech Incorporated (US), Centor Group (Netherlands), Michelman, Inc. (US), Precision Labs (US), CR Minerals, LLC (US), and Universal Coating Systems (US).Get 10% Free Customization on this Report:
More news about: MarketsandMarkets
Aug 24, 2026, 09:03 ET Crunch Fitness Franchisee Announces TRAINing Day, Giving Away 2 million Personal Training Sessions
part of the one-day event, more than 1 million CR Fitness Holdings members will have access to two complimentary 30-minute personal training sessions, totaling 2 million free sessions across the franchise group. All three CR Fitness Holdings entities – CR Fitness Holdings LLC, Southwest Fitness Holdings,
More news about: CR Fitness Holdings, LLC.
Aug 24, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
DCL Issuer25470D CR8US25470DCR89
More news about: Paramount Skydance Corporation
Aug 23, 2026, 21:00 ET Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
mg/kg, the ORR was 28.6% (6/21) and the DCR was 52.4% (11/21). In addition, one patient in each of the three cohorts achieved a complete response (CR). These results demonstrated the robust anti-tumor activity of ATG-022 across all levels of CLDN18.2 expression.Favorable safety profile:
More news about: Antengene Corporation Limited
Aug 20, 2026, 08:00 ET Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
263534CR8 US263534CR89$
More news about: Corteva Agriscience